These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33185469)

  • 1. Regaining Control: Anxiety in Sickle Cell Disease.
    McCoy B; Jaffe RJ; Coffey BJ
    J Child Adolesc Psychopharmacol; 2020 Nov; 30(9):572-575. PubMed ID: 33185469
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of pain rehabilitation in an adolescent sickle cell disease population: a case series.
    Collins AB; McTate-Acosta EA; Williams SE
    Pediatr Hematol Oncol; 2020 Oct; 37(7):637-644. PubMed ID: 32401110
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term use of hydroxyurea for sickle cell anemia.
    Hagar W
    JAMA; 2003 Aug; 290(6):753; author reply 754. PubMed ID: 12915424
    [No Abstract]   [Full Text] [Related]  

  • 4. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea.
    Stettler N; McKiernan CM; Melin CQ; Adejoro OO; Walczak NB
    JAMA; 2015 Apr; 313(16):1671-2. PubMed ID: 25919532
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia.
    DeBaun MR
    J Pediatr; 2005 Oct; 147(4):560-1. PubMed ID: 16227052
    [No Abstract]   [Full Text] [Related]  

  • 6. Sickle cell disease: What all PAs should know.
    Kayinqo G
    JAAPA; 2012 Sep; 25(9):19-20. PubMed ID: 22991882
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.
    Zahr RS; Hankins JS; Kang G; Li C; Wang WC; Lebensburger J; Estepp JH
    Am J Hematol; 2019 Jan; 94(1):E27-E29. PubMed ID: 30359463
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyurea for ALL children with sickle cell anemia: What can we learn from Africa?
    Aygun B
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28164. PubMed ID: 31925887
    [No Abstract]   [Full Text] [Related]  

  • 9. Expanding the role of hydroxyurea in children with sickle cell disease.
    Rogers ZR; Buchanan GR
    J Pediatr; 2004 Sep; 145(3):287-8. PubMed ID: 15343174
    [No Abstract]   [Full Text] [Related]  

  • 10. Onychotillomania in the course of depression: a case report.
    Grzesiak M; Pacan P; Reich A; Szepietowski JC
    Acta Derm Venereol; 2014 Nov; 94(6):745-6. PubMed ID: 24514910
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyurea for the treatment of sickle cell anemia.
    Platt OS
    N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical care of adult patients with sickle cell disease.
    Olujohungbe A; Howard J
    Br J Hosp Med (Lond); 2008 Nov; 69(11):616-9. PubMed ID: 19069260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR
    Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea marketed for sickle cell anemia.
    Am J Health Syst Pharm; 1998 May; 55(9):875. PubMed ID: 9588244
    [No Abstract]   [Full Text] [Related]  

  • 16. Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial.
    Sánchez LM; Nieves RM; Latham T; Stuber S; Luden JR; Urcuyo GS; Berges ME; Florencio C; Gonzalez C; Del Villar P; Lane A; Schultz W; Jeste N; Mena R; Ware RE
    Blood Adv; 2018 Nov; 2(Suppl 1):50-53. PubMed ID: 30504201
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyurea for sickle cell anemia.
    Naina HV; Harris S
    N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term use of hydroxyurea for sickle cell anemia.
    Lee DA; Mueller BU
    JAMA; 2003 Aug; 290(6):753-4; author reply 754. PubMed ID: 12915425
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary hypertension of sickle cell disease: new guidelines.
    Furlow B
    Lancet Respir Med; 2014 Apr; 2(4):263. PubMed ID: 24949502
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyurea for Sickle Cell Disease: Now Is the Time!
    Strouse JJ
    South Med J; 2016 Sep; 109(9):535-7. PubMed ID: 27598356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.